| Timeframe | Predicted Price | Past | Historical | Insight |
|---|---|---|---|---|
| Tomorrow | $7.82 ▲ +1.33% | Yesterday | $7.68 ▼ -0.56% | Tomorrow's ImmuCell Corporation Common Stock (ICCC) setup is anchored to $7.72 and targets $7.82 (+1.33%). The near-term read is upside; watch $7.95 / $7.49 because daily realized volatility is about 6.84%. |
Tomorrow's ImmuCell Corporation Common Stock (ICCC) setup is anchored to $7.72 and targets $7.82 (+1.33%). The near-term read is upside; watch $7.95 / $7.49 because daily realized volatility is about 6.84%. | ||||
| Week | $8.04 ▲ +4.12% | Last Week | $7.59 ▼ -1.73% | The 7-day ImmuCell Corporation Common Stock model moves from $7.59 to $8.04 (+4.12%). It gives upside momentum context for this stock, so breaks around $7.95 / $7.49 matter more than a single tick. |
The 7-day ImmuCell Corporation Common Stock model moves from $7.59 to $8.04 (+4.12%). It gives upside momentum context for this stock, so breaks around $7.95 / $7.49 matter more than a single tick. | ||||
| Month | $8.40 ▲ +8.79% | Last Month | $7.44 ▼ -3.69% | The 1-month ImmuCell Corporation Common Stock target is $8.40 (+8.79%), compared with the live reference near $7.72. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. |
The 1-month ImmuCell Corporation Common Stock target is $8.40 (+8.79%), compared with the live reference near $7.72. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. | ||||
| Year | $8.94 ▲ +15.77% | Last Year | $7.21 ▼ -6.62% | The 1-year ImmuCell Corporation Common Stock scenario points to $8.94 (+15.77%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. |
The 1-year ImmuCell Corporation Common Stock scenario points to $8.94 (+15.77%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. | ||||
| 5 Years | $10.20 ▲ +32.14% | 5 Years Ago | $6.68 ▼ -13.50% | The 5-year ImmuCell Corporation Common Stock view is $10.20 (+32.14%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. |
The 5-year ImmuCell Corporation Common Stock view is $10.20 (+32.14%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. | ||||
| Indicator | Value | Signal |
|---|---|---|
| Price | $7.72 | Mid |
| Daily Change | -3.74% | Below |
| Volatility Cap | 20.0% | Mid |
| Confidence | 65% | Above |
| Data Source | nasdaq-screener | Mid |
| Current | $7.72 | Daily Change | -3.74% |
| Market Cap | $69.84M | Source | nasdaq-screener |
Related ideas for internal navigation, grouped by stronger upside and weaker downside setups in the same market.